Immunovant, Inc. (IMVT) Retained Earnings (Accumulated Deficit) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Immunovant, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2018 to 2024.
  • Immunovant, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$826 M, a 45.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$826 M -$259 M -45.8% Mar 31, 2024 10-K 2024-05-29
Q4 2023 -$750 M -$243 M -48% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 -$699 M -$255 M -57.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$640 M -$245 M -61.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$566 M -$211 M -59.4% Mar 31, 2023 10-K 2024-05-29
Q4 2022 -$507 M -$199 M -64.5% Dec 31, 2022 10-Q 2023-02-03
Q3 2022 -$444 M -$177 M -66.3% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 -$396 M -$167 M -72.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 -$355 M -$157 M -78.9% Mar 31, 2022 10-K 2023-05-22
Q4 2021 -$308 M -$138 M -80.8% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 -$267 M -$128 M -92.3% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 -$229 M -$111 M -94.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$199 M -$107 M -118% Mar 31, 2021 10-K 2022-06-08
Q4 2020 -$170 M -$99.8 M -141% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 -$139 M -$139 M -45295% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$118 M -$118 M -64952% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 -$91.2 M -$66.4 M -267% Mar 31, 2020 10-K 2021-06-01
Q4 2019 -$70.7 M -$70.7 M -15775570% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $307 K* Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $182 K* Jun 30, 2019 10-Q 2019-08-12
Q1 2019 -$24.8 M Mar 31, 2019 10-K 2020-06-29
Q4 2018 -$448* Dec 31, 2018 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.